PTX3在曲霉感染中的作用

摘要/Abstract

中图分类号:

R519.8

黄越, 李航, 张克明, 卢晓迪, 张蕾, 廖万清, 潘炜华. PTX3在曲霉感染中的作用[J]. 中国真菌学杂志, 2023, 18(1): 86-89,96.

[1] ARASTEHFAR A, CARVALHO A, HOUBRAKEN J, et al. Aspergillus fumigatus and aspergillosis:From basics to clinics[J]. Stud Mycol, 2021, 100:100115. DOI:10.1016/j.simyco.2021.100115.
[2] GEYER C E, MES L, NEWLING M, et al. Physiological and pathological inflammation induced by antibodies and pentraxins[J]. Cells, 2021, 10(5):1175.
[3] BASILE A, SICA A, D'ANIELLO E, et al. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation[J]. J Biol Chem, 1997, 272(13):8172-8178.
[4] JAILLON S, PERI G, DELNESTE Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps[J]. J Exp Med, 2007, 204(4):793-804.
[5] THAKUR R, SHANKAR J. In silicoanalysis revealed high-risk single nucleotide polymorphisms in human pentraxin-3 gene and their impact on innate immune response against microbial pathogens[J]. Front Microbiol, 2016, 7:192. DOI:10.3389/fmicb.2016.00192.
[6] GARLANDA C, HIRSCH E, BOZZA S, et al. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response[J]. Nature, 2002, 420(6912):182-186.
[7] GAZIANO R, BOZZA S, BELLOCCHIO S, et al. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals[J]. Antimicrob Agents Chemother, 2004, 48(11):4414-4421.
[8] LO GIUDICE P, CAMPO S, VERDOLIVA A, et al. Efficacy of PTX3 in a rat model of invasive aspergillosis[J]. Antimicrob Agents Chemother, 2010, 54(10):4513-4515.
[9] LO GIUDICE P, CAMPO S, DE SANTIS R, et al. Effect of PTX3 andvoriconazole combination in a rat model of invasive pulmonary aspergillosis[J]. Antimicrob Agents Chemother, 2012, 56(12):6400-6402.
[10] MARRA E, SOUSA V L, GAZIANO R, et al. Efficacy of PTX3 and posaconazole combination in a rat model of invasive pulmonary aspergillosis[J]. Antimicrob Agents Chemother, 2014, 58(10):6284-6286.
[11] BOTTAZZI B, VOURET-CRAVIARI V, BASTONE A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component[J]. J Biol Chem, 1997, 272(52):32817-32823.
[12] NAUTA A J, BOTTAZZI B, MANTOVANI A, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q[J]. Eur J Immunol, 2003, 33(2):465-473.
[13] DEBAN L, JARVA H, LEHTINEN M J, et al. Binding of the long pentraxin PTX3 to factor H:interacting domains and function in the regulation of complement activation[J]. J Immunol, 2008, 181(12):8433-8440.
[14] MA Y J, DONI A, HUMMELSHOJ T, et al. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition[J]. J Biol Chem, 2009, 284(41):28263-28275.
[15] MA Y J, DONI A, ROMANI L, et al. Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production[J]. J Immunol, 2013, 191(3):1324-1333.
[16] MOALLI F, DONI A, DEBAN L, et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus[J]. Blood, 2010, 116(24):5170-5180.
[17] BELLOCCHIO S, MONTAGNOLI C, BOZZA S, et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo[J]. J Immunol, 2004, 172(5):3059-3069.
[18] SHIMAZU R, AKASHI S, OGATA H, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4[J]. J Exp Med, 1999,189(11):1777-1782.
[19] AKASHI S, SAITOH S, WAKABAYASHI Y, et al. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2:higher affinity than that with MD-2 or CD14[J]. J Exp Med, 2003, 198(7):1035-1042.
[20] BOZZA S, CAMPO S, ARSENI B, et al. PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis[J]. J Immunol, 2014, 193(5):2340-2348.
[21] RUIZ-CAMPS I, AGUADO J M, ALMIRANTE B, et al. Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)[J]. Clin Microbiol Infect, 2011, 17(Suppl 2):1-24.
[22] RUPING M J, VEHRESCHILD J J, CORNELY O A. Patients at high risk of invasive fungal infections:when and how to treat[J]. Drugs, 2008, 68(14):1941-1962.
[23] FISHER C E, HOHL T M, FAN W, et al. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation[J]. Blood, 2017, 129(19):2693-2701.
[24] PLANTINGA T S, VAN DER VELDEN W J, FERWERDA B, et al. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients[J]. Clin Infect Dis, 2009, 49(5):724-732.
[25] CUNHA C, DI IANNI M, BOZZA S, et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity[J]. Blood, 2010, 116(24):5394-5402.
[26] KALKANCI A, TUG E, FIDAN I, et al. Retrospective analysis of the association of the expression and single nucleotide polymorphisms (SNPs) of the TLR4, PTX3 and Dectin-1 (CLEC/A) genes with development of invasive aspergillosis among haematopoietic stem cell transplant recipients with oncohaematological disorders[J].Mycoses, 2020, 63(8):832-839.
[27] HERRERO-SANCHEZ M C, ANGOMAS E B, DE RAMON C, et al. Polymorphisms inreceptors involved in opsonic and nonopsonic phagocytosis, and correlation with risk of infection in oncohematology patients[J]. Infect Immun, 2018, 86(12). DOI:10.1128/IAI.00709-18.
[28] BIAGI E, COL M, MIGLIAVACCA M, et al. PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients[J]. J Pediatr Hematol Oncol, 2008, 30(12):881-885.
[29] KONTOYIANNIS D P, MARR K A, PARK B J, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006:overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database[J]. Clin Infect Dis, 2010, 50(8):1091-1100.
[30] PAGANO L, CAIRA M, NOSARI A, et al. Fungal infections in recipients of hematopoietic stem cell transplants:results of the SEIFEM B-2004 study:Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne[J]. Clin Infect Dis, 2007, 45(9):1161-1170.
[31] PAPPAS P G, ALEXANDER B D, ANDES D R, et al. Invasive fungal infections among organ transplant recipients:results of the Transplant-Associated Infection Surveillance Network (TRANSNET)[J]. Clin Infect Dis, 2010, 50(8):1101-1111.
[32] BONGOMIN F, GAGO S, OLADELE R O, et al. Global andmulti-national prevalence of fungal diseases-estimate precision[J]. J Fungi (Basel), 2017, 3(4):57.
[33] CUNHA C, AVERSA F, LACERDA J F, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation[J]. N Engl J Med, 2014, 370(5):421-432.
[34] WONG S S W, RASID O, LASKARIS P, et al. Treatment of cyclosporin A retains host defense against invasive pulmonary aspergillosis in a non-immunosuppressive murine model by preserving the myeloid cell population[J]. Virulence, 2017, 8(8):1744-1752.
[35] ZELANTE T, WONG A Y, MENCARELLI A, et al. Impaired calcineurinsignaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis [J]. Mucosal Immunol, 2017, 10(2): 470-480. [36] CUNHA C, MONTEIRO A A, OLIVEIRA-COELHO A, et al. PTX3-based genetic testing for risk of aspergillosis after lung transplant [J]. Clin Infect Dis, 2015, 61(12): 1893-1894. [37] BRUNEL A S, WOJTOWICZ A, LAMOTH F, et al. Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy [J]. Haematologica, 2018, 103(11): e527-e530. [38] WOJTOWICZ A, LECOMPTE T D, BIBERT S, et al. PTX3 polymorphisms and invasive mold infections after solid organ transplant [J]. Clin Infect Dis, 2015, 61(4): 619-622. [39] HE Q, LI H, RUI Y, et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients [J]. Clin Infect Dis, 2018, 66(2): 261-267. [40] LI H, LIU L, ZHOU W, et al. Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis [J]. Clin Microbiol Infect, 2019, 25(4): 504-510. [41] TANG T, DAI Y, ZENG Q, et al. Pentraxin-3 polymorphisms and pulmonary fungal disease in non-neutropenic patients [J]. Ann Transl Med, 2020, 8(18): 1142. [42] NATH R, BARUAH S, SAIKIA L, et al. Mycotic corneal ulcers in upper Assam [J]. Indian J Ophthalmol, 2011, 59(5): 367-371. [43] CHOWDHARY A, SINGH K. Spectrum of fungal keratitis in North India [J]. Cornea, 2005, 24(1): 8-15. [44] XIE L, ZHONG W, SHI W, et al. Spectrum of fungal keratitis in north China [J]. Ophthalmology, 2006, 113(11): 1943-1948. [45] GUPTA M K, CHANDRA A, PRAKASH P, et al. Fungal keratitis in north India; Spectrum and diagnosis by Calcofluor white stain [J]. Indian J Med Microbiol, 2015, 33(3): 462-463. [46] MAHMOUDI S, MASOOMI A, AHMADIKIA K, et al. Fungal keratitis: An overview of clinical and laboratory aspects [J]. Mycoses, 2018, 61(12): 916-930. [47] ZHANG J, ZHAO G Q, QU J, et al. Early expression of PTX3 in Aspergillus fumigatus infected rat cornea [J]. Int J Ophthalmol, 2018, 11(7): 1084-1089. [48] ZHANG J, ZHAO G, LIN J, et al. Role of PTX3 in corneal epithelial innate immunity against Aspergillus fumigatus infection[J]. Exp Eye Res, 2018, 167: 152-162. DOI: 10.1016/j.exer.2016.11.017.

PTX3在曲霉感染中的作用

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	房凌旭, 杨丽娜, 江川, 卢中一, 陈芳艳, 韩黎. 小GTPase蛋白在烟曲霉耐药性和致病力中作用的研究进展[J]. 中国真菌学杂志, 2023, 18(1): 49-52.
[2]	王思琦, 马彦. 烟曲霉生物膜耐药性研究进展[J]. 中国真菌学杂志, 2023, 18(1): 53-57.
[3]	周宸, 卢家桀. 烟曲霉感染性心内膜炎1例[J]. 中国真菌学杂志, 2022, 17(6): 486-489.
[4]	洪翩翩, 陈玉萍, 郑楠, 刘沐桑. 烟曲霉cyp51A基因序列BLAST数据库的建立[J]. 中国真菌学杂志, 2022, 17(5): 353-358.
[5]	李博志, 曹霞, 郭宏伟, 胡怀强, 曹秉振. 糖尿病酮症酸中毒合并鼻-眼-脑曲霉感染1例[J]. 中国真菌学杂志, 2022, 17(4): 311-314.
[6]	李姝丽, 吴秀祯, 王志贤, 盛长忠, 周泽奇, 陈龙. 烟曲霉唑类药物耐药检测方法研究进展[J]. 中国真菌学杂志, 2022, 17(4): 335-338.
[7]	谢晶晶, 杨江科, 代江红. 新冠肺炎大流行中的真菌感染[J]. 中国真菌学杂志, 2022, 17(3): 260-264.
[8]	徐凤娇, 娄新宇, 王远舟, 韩子宇, 仲国维. 烟曲霉孢子侵染小鼠骨髓源巨噬细胞的转录组研究[J]. 中国真菌学杂志, 2022, 17(2): 94-98.
[9]	陈显振, 朱信霖, 姜伟伟, 扈东营, 张克明, 方文捷, 潘炜华, 刘晓刚, 廖万清. 烟酰胺及联合伊曲康唑体外抗烟曲霉活性研究[J]. 中国真菌学杂志, 2022, 17(2): 124-128.
[10]	张传明, 曹泓宇, 孙继德, 牛司强, 王詝, 蒲姝丽, 徐绣宇. 血清和支气管肺泡灌洗液GM试验对非粒细胞缺乏患者不同类型肺曲霉病的诊断价值分析[J]. 中国真菌学杂志, 2022, 17(2): 146-151.
[11]	陈晨, 贺彬婵, 朱益敏, 赵蓓蕾, 陈菲, 徐小勇. 烟曲霉的细胞外囊泡蛋白质及RNA分析[J]. 中国真菌学杂志, 2022, 17(1): 8-11,26.
[12]	王淑玲, 李艳敏, 张震, 王丽英, 颜令, 徐兰兰, 廖璞. 继发肺结核合并两株不同表型烟曲霉感染病例1例[J]. 中国真菌学杂志, 2022, 17(1): 44-48.
[13]	陈显振, 方文捷, 朱信霖, 廖万清, 潘炜华. 烟曲霉的蛋白质翻译后修饰研究进展[J]. 中国真菌学杂志, 2022, 17(1): 64-68,73.
[14]	高飞飞, 马彦. 烟曲霉相关基因、转录因子在其细胞壁重塑、稳态和生长定位中的作用[J]. 中国真菌学杂志, 2022, 17(1): 74-77.
[15]	谢韵, 帕丽达·阿布利孜. 临床罕见曲霉菌属的研究进展[J]. 中国真菌学杂志, 2022, 17(1): 84-88.